Vermedx
Burlington, US · Delaware corporation · 1 known investors
Healthtech
Founders & leadership
SG
Stanley GoldsteinExecutive
MM
Michael MacCaskeyExecutive
BL
Benjamin LittenbergNamed on SEC filing
SM
Stanley M. GoldsteinNamed on SEC filing
Board
LB
HT
Henry TufoBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$509.6K disclosed across 2 rounds · 2014–2015
▶$250.6KraisedMay 2015 · 11 investors · Other Health CareRule 506(b)
▶$250.6KraisedMay 2015 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Henry TufoDirector
- Stanley GoldsteinExecutive Officer, Director
- Lee BouyeaDirector
- Benjamin LittenbergExecutive Officer, Director
- Michael MacCaskeyExecutive Officer
- Offering amount
- $500K
- Amount sold
- $250.6K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$259KraisedFeb 2014 · 11 investors · Other Health CareRule 506(b)
▶$259KraisedFeb 2014 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin LittenbergExecutive Officer, Director
- Lee BouyeaDirector
- Michael MacCaskeyExecutive Officer
- Stanley M. GoldsteinExecutive Officer, Director
- Henry TufoDirector
- Offering amount
- $400K
- Amount sold
- $259K
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Vermedx's investors?
- Vermedx's investors include FreshTracks Capital.
- How much funding has Vermedx raised?
- Vermedx has disclosed $509.6K raised across 2 rounds.
- Where is Vermedx headquartered?
- Vermedx is headquartered in Burlington, US.